https://www.thebodypro.com/author/myles-helfand
Myles Helfand Img

Myles Helfand

Executive Editor

Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro. A career journalist and editor, Myles joined TheBody in 2001 as a part-time copyeditor. He has since established himself as a leading journalist and content strategist on HIV-related issues, authoring hundreds of articles and editing hundreds more—and accumulating an ever-growing mountain of HIV conference badges along the way.

Latest by Myles Helfand

risk dominoes
News

This Week in HIV Research: Correlates of Risk

July 29, 2021: Racial disparities in hospitalization rates; city-specific mortality demographics; effects of traditional risk factors vs. antiretrovirals on weight gain and cardiovascular risk.

By Barbara Jungwirth and Myles Helfand
spider web
News

This Week in HIV Research: Anxiety’s Tangled Web

July 22, 2021: How HIV criminalization laws may reduce disclosure; anxiety and housing satisfaction; poor immune response to delayed ART; the U.S.'s HIV testing mountain.

By Barbara Jungwirth and Myles Helfand
Researchers on a Zoom call during an IAS 2021 press conference
Conference Coverage

IAS 2021 Data Bites: HIV Treatment and Drugs in Development

Our quick summaries of breaking conference research include new study findings on injectable long-acting cabotegravir/rilpivirine and the latest on lenacapavir, a twice-yearly injectable medication in the pipeline.

By Larry Buhl and Myles Helfand
ducks in row
News

This Week in HIV Research: A Break in the Pattern

July 15, 2021: Mind existing drug interactions when switching ART; lamivudine dosing amidst renal impairment; HPV vaccination among MSM; cervical cancer screening for women with HIV.

By Myles Helfand
Close-up of a blue-eyed senior man
News

This Week in HIV Research: Older and Wiser

July 8, 2021: Trends among heavily treatment-experienced PLWH; a new look at peripheral neuropathy factors; heart transplantation in PLWH; complications following successful HCV treatment.

By Barbara Jungwirth and Myles Helfand
medical scale
News

This Week in HIV Research: Tipping the Scales

June 24, 2021: Effect of efavirenz metabolism on weight change; determinants of weight gain when switching meds; metabolic effects of DTG vs. TAF; food security vs. nutrition security.

By Barbara Jungwirth and Myles Helfand
Truvada
News

This Week in HIV Research: The Realities of PrEP

June 17, 2021: PrEP awareness vs. PrEP willingness among young Black women; acute HIV infection during PrEP initiation; real-world PrEP efficacy; HIV rates by U.S. region among transgender people.

By Barbara Jungwirth and Myles Helfand
nurse patient hands
Reference

What's New in U.S. HIV Clinical Treatment Guidelines

The latest update to official guidelines issued by the U.S. Department of Health and Human Services occurred within the adult/adolescent guidelines on June 3.

By Myles Helfand
burden
News

This Week in HIV Research: The Burdens We Bear

June 10, 2021: Trauma, burden, and COVID-19 risk among PLWH; sleep and viral suppression; spirituality/religioisity, depression, and HIV risk; why anal cancer screening isn't enough.

By Barbara Jungwirth and Myles Helfand
HIV people
News

This Week in HIV Research: It’s Not Just About HIV

June 3, 2021: Kaposi sarcoma despite ART; heat-based cervical HPV treatment; re-evaluating HIV-associated neurocognitive disorder; HIV and diabetes in Texas.

By Barbara Jungwirth and Myles Helfand